Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1997 Jan;10(1):34-49.
doi: 10.2165/00002512-199710010-00004.

Cancer chemotherapy in older adults. A tolerability perspective

Affiliations
Review

Cancer chemotherapy in older adults. A tolerability perspective

G G Kimmick et al. Drugs Aging. 1997 Jan.

Abstract

The incidence of cancer increases with age. Since the geriatric population is growing, we will be confronted with an increasing number of patients with cancer who are > 65 years of age. The purpose of this review is to address the use of cancer chemotherapy in older persons with respect to its tolerability. We performed a review of the literature using 'Medline' and the bibliographies of pertinent publications. Information about cancer treatment in older adults was extracted with particular attention to chemotherapy-related toxicity in patients aged > 65 years. Comorbid disease, polypharmacy/drug interactions, psychosocial issues and age-related physiological changes are major issues in caring for older patients with cancer. Since older individuals may have a greater number of comorbid illnesses, treatment should be initiated on the basis of physiological rather than chronological age. Comparative studies show that chemotherapy-related toxicity is similar in older and younger patients, with the exception of haematological toxicity, which may be more severe in older patients, and cardiotoxicity, which is more frequent in the elderly. Other evidence suggests that gastrointestinal and neurotoxicities may also be more severe in older individuals. The dosages of chemotherapeutic agents that are primarily renally excreted may require adjustment in older patients. Haematological reserve is decrease in older individuals, and drugs that cause myelosuppression must be used with care. The use of haemopoietic growth factors in geriatric patients is currently being investigated.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Oncol. 1988 Oct;6(10):1611-20 - PubMed
    1. J Am Geriatr Soc. 1965 Mar;13:192-8 - PubMed
    1. Anticancer Res. 1992 Jan-Feb;12(1):231-4 - PubMed
    1. Cancer. 1987 Oct 1;60(7):1439-41 - PubMed
    1. J Clin Oncol. 1994 Oct;12(10):2121-5 - PubMed

Substances

LinkOut - more resources